SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Shareholders' Equity
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Shareholders' Equity of $19.18 million as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-24
- 2026-06-30: Stockholders' Equity Attributable to Parent $19.18M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.35M; Stockholders' Equity Attributable to Parent as first filed $3.35M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.25M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.39M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $19.18M 10-Q · filed 2026-09-24 | |
| 2026-03-31 | $3.35M 10-Q · filed 2026-09-24 | $3.35M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.25M 10-Q · filed 2026-09-24 | |
| 2025-09-30 | $1.39M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.61M 10-Q · filed 2026-09-24 | |
| 2025-03-31 | $3.29M 10-Q · filed 2026-09-24 | |
| 2024-12-31 | $709.15K 10-Q · filed 2026-09-24 | |
| 2024-09-30 | -$1.32M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $801.43K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $2.76M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $4.06M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $5.61M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $6.94M 10-Q · filed 2024-11-13 | $6.94M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $6.91M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $7.68M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $8.40M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$2.31M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | -$1.85M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | -$1.76M 10-K/A · filed 2024-09-04 | -$1.63M 10-Q · filed 2022-11-14 |
| 2021-09-30 | -$2.09M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$1.97M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$1.72M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$1.69M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |